CDGLY yields 5.05% · JNJ yields 3.36%● Live data
📍 CDGLY pulled ahead of the other in Year 1
Combined, CDGLY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CDGLY + JNJ for your $10,000?
ComfortDelGro Corporation Limited, an investment holding company, provides public transport services in Singapore. It operates through seven segments: Public Transport Services, Taxi, Automotive Engineering Services, Inspection and Testing Services, Driving Centre, Car Rental and Leasing, and Bus Station. The company offers bus and rail services to commuters; taxi and coach rental, and related advertisement services; non-emergency transport services to patients; vehicular maintenance and repair services; assembly of bus bodies; crash repair services; and engineering services, as well as sells diesel and petrol. It is also involved in the provision of motor vehicle inspection, non-vehicle testing, inspection, and consultancy services; construction of specialized vehicles; operation of taxi bureau, scheduled services, and driving schools; electric vehicle charging infrastructure activities; and renting and leasing of cars. In addition, the company offers public taxi and charter bus, management of taxi booking, building inspection, technology, and terminal services; and operates workshops for repairing, servicing, and general maintenance of motor vehicles. Further, it provides insurance broking, risk management, claims management, and related services; medical escort services; charge card facilities; and accident and other repair and maintenance services. As of March 30, 2022, the company operated a fleet of 35,000 buses, taxis, and rental vehicles. It also operates in the United Kingdom, Ireland, Australia, China, New Zealand, and Malaysia. ComfortDelGro Corporation Limited was incorporated in 2003 and is headquartered in Singapore.
Full CDGLY Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.